Skip to main content

Table 3 Sedative drugs administered to each patient group

From: Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital

 

Intermittent only (n = 72)

Switched to continuous (n = 37)

Initially continuous (n = 11)

Total

 

Non-DNI (n = 28)

DNI (n = 44)

Non-DNI (n = 8)

DNI (n = 29)

Non-DNI (n = 3)

DNI (n = 8)

n = 120

Risperidone

13 (46 %)

20 (45 %)

5 (63 %)

13 (45 %)

  

51 (43 %)

Haloperidol

20 (71 %)

35 (80 %)

8 (100 %)

24 (83 %)

  

87 (73 %)

Others

0 (0 %)

10 (23 %)

1 (13 %)

0 (0 %)

  

11 (9 %)

Dexmedetomidine

  

4 (50 %)

10 (34 %)

0 (0 %)

4 (50 %)

18 (15 %)

Midazolam

  

3 (38 %)

5 (17 %)

0 (0 %)

3 (38 %)

11 (9 %)

Propofol

  

3 (38 %)

10 (34 %)

1 (33 %)

2 (25 %)

16 (13 %)

Morphine

  

1 (13 %)

16 (55 %)

2 (67 %)

4 (50 %)

23 (19 %)

Fentanyl

  

3 (38 %)

6 (21 %)

1 (33 %)

1 (13 %)

11 (9 %)

  1. Number (%) for each sedative drug reflects use of more than 1 drug per patient
  2. DNI do-not-intubate